545 Results

People

  1. Motzer
    Motzer
  2. Bosl
    Bosl
  3. Sheinfeld
    Sheinfeld
  4. Yahalom
    Yahalom
  5. Bajorin
    Bajorin
  6. Straus
    Straus
  7. Feldman
    Feldman
  8. Kelsen
    Kelsen
  9. Moskowitz
    Moskowitz
  10. Herr
    Herr

Groups

  1. Department of Medicine (281)
  2. Survivorship Research (171)
  3. Solid Tumor Oncology Division (166)
  4. Surgery (130)
  5. Hematologic Malignancies, Division of (113)
  6. Center for Hematologic Malignancies (112)
  7. Genitourinary Oncology Service (91)
  8. Lymphoma (88)
  9. Urology (60)
  10. Radiation Oncology, Department of (58)
  1. "bleomycin"
Formats
  1. Journal Article (520)
  2. Conference Paper (11)
  3. Review (5)
  4. Editorial (3)
  5. Meeting Abstract (3)
  6. Book Section (1)
  7. Guidelines (1)
  8. Research Letter (1)
Groups
  1. Department of Medicine (281)
  2. Survivorship Research (171)
  3. Solid Tumor Oncology Division (166)
  4. Surgery (130)
  5. Hematologic Malignancies, Division of (113)
  6. Center for Hematologic Malignancies (112)

More Groups

People
  1. George Bosl (85)
  2. Robert Motzer (59)
  3. Joel Sheinfeld (44)
  4. David Straus (41)
  5. Joachim Yahalom (39)
  6. Dean Bajorin (36)

More People

Years
  1. 2025 (5)
  2. 2024 (14)
  3. 2023 (2)
  4. 2022 (6)
  5. 2021 (11)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (66)
  2. Cancer (38)
  3. Seminars in Oncology (22)
  4. Gynecologic Oncology (19)
  5. Journal of the National Comprehensive Cancer Network (18)
  6. International Journal of Radiation Oncology, Biology, Physics (12)

More Publications

Publishers
  1. Elsevier Inc. (100)
  2. American Society of Clinical Oncology (66)
  3. Wiley Blackwell (53)
  4. Lippincott Williams & Wilkins (32)
  5. Springer (28)
  6. Oxford University Press (24)

More Publishers

Results (545)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Positron emission tomography-adapted therapy in bulky stage I/II classic Hodgkin lymphoma: CALGB 50801 (Alliance)
    Journal Article

    LaCasce, A. S.; Dockter, T.; Ruppert, A. S.; Kostakoglu, L.; Schöder, H.; Hsi, E.; Bogart, J.; Cheson, B.; Wagner-Johnston, N.; Abramson, J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Overall survival with brentuximab vedotin in stage III or IV Hodgkin's lymphoma
    Journal Article

    Ansell, S. M.; Radford, J.; Connors, J. M.; Długosz-Danecka, M.; Kim, W. S.; Gallamini, A.; Ramchandren, R.; Friedberg, J. W.; Advani, R.; Hutchings, M.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • The ABVD’s of cooperative trials in pediatric Hodgkin lymphoma: The India experience
    Editorial

    Rodriguez-Hernandez, A.; Giulino-Roth, L.
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Zenocutuzumab, a HER2XHER3 bispecific antibody, is effective therapy for tumors driven by NRG1 gene rearrangements
    Journal Article

    Schram, A. M.; Odintsov, I.; Espinosa-Cotton, M.; Khodos, I.; Sisso, W. J.; Mattar, M. S.; Lui, A. J. W.; Vojnic, M.; Shameem, S. H.; Chauhan, T.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: A detailed analysis from the phase III ECHELON-1 study
    Journal Article

    Evens, A. M.; Connors, J. M.; Younes, A.; Ansell, S. M.; Kim, W. S.; Radford, J.; Feldman, T.; Tuscano, J.; Savage, K. J.; Oki, Y.; more...
    Haematologica (2022)

    Fulltext@MSK | Save
  • Characteristics and outcome of extranodal NK/T-cell lymphoma in North America: A retrospective multi-institutional experience
    Journal Article

    Bennani, N. N.; Tun, A. M.; Carson, K. R.; Geiger, J. L.; Maeda, L. S.; Savage, K. J.; Rose, J.; Pinter-Brown, L.; Lunning, M. A.; Abramson, J. S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • A high-content screen for C/EBPα expression identifies novel therapeutic agents in dedifferentiated liposarcoma
    Journal Article

    Angeles, C. V.; Velez, A.; Rios, J.; Laxa, B.; Shum, D.; Ruiz, P. D.; Shen, Y.; Ostrovnaya, I.; Gularte-Mérida, R.; Nacev, B. A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Combination brentuximab vedotin and bendamustine for pediatric patients with relapsed/refractory Hodgkin lymphoma
    Journal Article

    Forlenza, C. J.; Gulati, N.; Mauguen, A.; Absalon, M. J.; Castellino, S. M.; Franklin, A.; Keller, F. G.; Shukla, N.
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Outcomes after multidisciplinary management of primary mediastinal germ cell tumors
    Journal Article

    Caso, R.; Jones, G. D.; Bains, M. S.; Hsu, M.; Tan, K. S.; Feldman, D. R.; Funt, S. A.; Reuter, V. E.; Bosl, G. J.; McHugh, D.; more...
    Annals of Surgery (2021)

    Fulltext@MSK | Save
  • Durable response to brentuximab vedotin plus cyclophosphamide, doxorubicin, and prednisone (BV-CHP) in a patient with CD30-positive PTCL arising as a post-transplant lymphoproliferative disorder (PTLD)
    Journal Article

    Hong, J.; Johnson, W. T.; Kartan, S.; Gonsalves, A. S.; Fenkel, J. M.; Gong, J. Z.; Porcu, P.
    Current Oncology (2021)

    Fulltext@MSK | Save